Quantitative analysis of colonization with real-time PCR to identify the role of Oxalobacter formigenes in calcium oxalate urolithiasis

Urological Research

Volumn 40, Issue 5, 2012, Pages 455-460

  Batislam, Ertan ^a   Yilmaz, Erdal ^a   Yuvanc, Ercan ^a   Kisa, Ozgul ^b   Kisa, Ucler ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Calcium; Oxalate; Oxalobacter formigenes; Real time PCR; Urolithiasis

Indexed keywords

CALCIUM; CREATININE; POTASSIUM; SODIUM; UREA;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CALCIUM BLOOD LEVEL; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; MALE; NONHUMAN; OXALATE URINE LEVEL; OXALOBACTER FORMIGENES; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE; SODIUM BLOOD LEVEL; UREA BLOOD LEVEL; URINE LEVEL;

ADOLESCENT; ADULT; CALCIUM OXALATE; FEMALE; GASTROINTESTINAL TRACT; HUMANS; HYPEROXALURIA; MALE; MIDDLE AGED; OXALOBACTER FORMIGENES; REAL-TIME POLYMERASE CHAIN REACTION; UROLITHIASIS;

EID: 84867900560     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-011-0449-8     Document Type: Article

References (29)

1. Menon M, Parulkar BG, Drach GW (1988) Urinary lithiasis: etiology, diagnosis and medical management. In: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ (eds) Campbell's Urology, vol III, 7th edn. W. B. Saunders Co., Philadelphia, pp 2659-2752
2. Goldfarb DS (2009) Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis 16:21-29
3. Borghi L, Meschi T, Maggiore U, Prati B (2006) Dietary therapy in idiopathic nephrolithiasis. Nutr Rev 64:301-312
4. Bruce AW, Reid G (2003) Probiotics and the urologist. Can J Urol 10:1785-1789
5. Duncan SH, Richardson AJ, Kaul P et al (2002) Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 68:3841-3847
6. Hatch M, Freel RW (2008) The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 28:143-151
7. Mittal RD, Kumar R (2004) Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis. J Endourol 18:418-424
8. Mittal RD, Kumar R, Bid HK et al (2005) Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol 19:102-106
9. Sidhu H, Allison M, Peck AB (1997) Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350-353
10. Troxel SA, Sidhu H, Kaul P et al (2003) Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 17:173-176
11. Mittal RD, Kumar R, Mittal B et al (2003) Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 12:208-213
12. Prokopovich S, Knight J, Assimos DG et al (2007) Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 178:2186-2190
13. Larionov A, Krause A, Miller W (2005) A standard curve-based method for relative real-time PCR data processing. BMC Bioinformatics 21(62):1-16
14. Sails AD (2004) Applications of real-time PCR in clinical microbiology. In: Edwards K, Logan J, Saunders N (eds) Real-time PCR: an essential guide. Horizon Biosci, Norfolk, pp 247-326
15. Neuhaus TJ, Belzer T, Blau N et al (2000) Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 82:322-326
16. Kleinschmidt K, Mahlmann A, Hautmann R (1994) Oxalate degrading bacteria in the gut: do they influence calcium oxalate stone formation? In: Ryall R, Bais R, Marshall VR (eds) Urolithiasis 2. Plenum Press, New York, pp 439-441
17. Hoppe B, Beck B, Gatter N et al (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305-1311
18. Sidhu H, Schmidt ME, Cornelius JG et al (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10(Suppl 14):S334-S340
19. Kaufman DW, Kelly JP, Curhan GC et al (2008) Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 19:1197-1203
20. Kwak C, Kim HK, Kim EC et al (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44:475-481
21. Siva S, Barrack ER, Reddy GP et al (2009) A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int 103:18-21
22. Sidhu H, Holmes RP, Allison MJ et al (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503-1509
23. Kharlamb V, Schelker J, Francois F et al (2011) Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 25:1781-1785
24. Kelly JP, Curhan GC, Cave DR et al (2011) Factors related to colonization with Oxalobacter formigenes in US adults. J Endourol 25:673-679
25. Hoppe B, Von Unruh G, Laube N et al (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33:372-375
26. Campieri C, Campieri M, Bertuzzi V et al (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097-1105
27. Watterson JD, Cadieux PA, Beiko DT et al (2003) Oxalatedegrading enzymes from Oxalobacter formigenes: a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol 17:269-274
28. Hoppe B, Dittlich K, Fehrenbach H et al (2011) Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis 58:453-455
29. Hoppe B, Groothoff JW, Hulton SA et al (2011) EYcacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transpl 26:3609-3615